326476-60-2

Upstream product

• 326476-70-4 2-benzyloxymethyl-but-2-enal 
• 1125-88-8 benzaldehyde dimethyl acetal 
• 104306-94-7 2-benzyloxymethyl-but-2-en-1-ol 
• 326476-67-9 5-ethylidene-2-phenyl-[1,3]dioxane 

Downstream Products

• 326476-73-7 1-(2-benzyloxymethyl-but-2-enoyl)-pyrrolidine-2-carboxylic acid 
• 326476-58-8 3-benzyloxymethyl-3-ethyl-tetrahydro-pyrrolo[2,1-c][1,4]oxazine-1,4-dione 
• 326476-83-9 2-benzyloxymethyl-N,N-diethyl-2-methoxymethoxy-butyramide 
• 326476-81-7 (S)-2-benzyloxymethyl-2-(methoxymethoxy)butanoic acid 
• 326476-79-3 2-benzyloxymethyl-2-methoxymethoxy-butyric acid methyl ester 
• 326476-56-6 (S)-2-Benzyloxymethyl-2-hydroxy-butyric acid 
• 326476-77-1 2-benzyloxymethyl-2-hydroxy-butyric acid methyl ester 
• 326476-71-5 1-(2-benzyloxymethyl-but-2-enoyl)-pyrrolidine-2-carboxylic acid methyl ester 

Relevant academic research and scientific papers

Enantioselective synthesis of (S)-N,N-diethyl-2-formyl-2-(methoxymethoxy)butyramide, a key intermediate for 20(S)-camptothecin analogues, via asymmetric bromolactonization

A new enantioselective synthetic method for enantiomerically pure (S)-N,N-diethyl-2-formyl-2-(methoxymethoxy)butyramide 5, a versatile key intermediate has been developed employing asymmetric bromolactonization using (S)-proline as the chiral auxiliary. C